CSL Behring Buys VitaerisAcquisitions, Assets, Business, Clinical Trials, Monoclonal Antibodies, R&D, Transplant RejectionCSL Behring, based in King of Prussia, Pennsylvania, is acquiring Vancouver, British Columbia-based Vitaeris. Read more June 9, 2020/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/06/CSL-Behring-Buys-Vitaeris-Picks-Up-Transplant-Rejection-Therapeutic-BioSpace-6-8-20.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2020-06-09 01:09:222020-06-15 19:15:55CSL Behring Buys Vitaeris
